Table 4.
Correlations between single polyphenolic intake and sociodemographic and health characteristics of Argentinian postpartum women (n=275)
| Intake | Zero-order correlation | Biserial-point correlation | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|||||||||
| Age | PD | BMI | BFP | MET | E | EL | Parity | EBF | ||
| Malvidin 3-O-glucoside | 0.121* | 0.102 | −0.145* | −0.096 | 0.000 | 0.059 | −0.005 | 0.100 | 0.068 | |
| (−)-Epicatechin | −0.038 | −0.029 | −0.112 | −0.120* | 0.235* | 0.018 | 0.028 | 0.015 | 0.053 | |
| (−)-Epigallocatechin 3-O-gallate | −0.128* | −0.024 | 0.013 | −0.032 | 0.166* | −0.092 | −0.048 | 0.028 | −0.039 | |
| (−)-Epicatechin 3-O-gallate | −0.119* | −0.016 | 0.004 | −0.037 | 0.169* | −0.088 | −0.046 | 0.033 | −0.035 | |
| (+)-Catechin | 0.081 | 0.088 | −0.151* | −0.116 | 0.184* | 0.045 | 0.068 | 0.056 | 0.025 | |
| (+)-Gallocatechin | −0.128* | −0.024 | 0.013 | −0.032 | 0.166* | −0.092 | −0.048 | 0.028 | −0.038 | |
| Procyanidin dimer B2 | −0.008 | −0.028 | −0.095 | −0.092 | 0.180* | 0.017 | 0.045 | −0.006 | 0.080 | |
| Hesperetin | −0.025 | −0.112 | 0.029 | 0.004 | 0.120* | 0.058 | −0.084 | 0.001 | −0.038 | |
| Naringenin | 0.003 | −0.096 | 0.022 | 0.002 | 0.155* | 0.068 | −0.037 | −0.017 | −0.005 | |
| Quercetin | 0.040 | 0.073 | −0.149* | −0.140* | 0.239* | 0.072 | 0.117* | −0.009 | 0.003 | |
| Quercetin 3-O-rutinoside | 0.059 | 0.128* | 0.015 | −0.101 | −0.038 | 0.127* | 0.049 | 0.022 | −0.051 | |
| 5-O-Galloylquinic acid | −0.128* | −0.024 | 0.013 | −0.032 | 0.166* | −0.092 | −0.048 | 0.028 | −0.039 | |
| Syringic acid | −0.044 | 0.123* | −0.101 | −0.109 | 0.090 | −0.028 | 0.092 | −0.151* | −0.037 | |
| 1-Caffeoyl quinic acid | 0.061 | 0.122* | 0.023 | −0.092 | −0.059 | 0.126* | 0.046 | 0.017 | −0.046 | |
| 1,3-Dicaffeoylquinic | 0.061 | 0.122* | 0.023 | −0.092 | −0.059 | 0.126* | 0.046 | 0.017 | −0.046 | |
| 1,4-Dicaffeoylquinic | 0.061 | 0.122* | 0.023 | −0.092 | −0.059 | 0.126* | 0.046 | 0.017 | −0.046 | |
| 3,4-Dicaffeoylquinic acid | 0.077 | 0.136* | 0.013 | −0.096 | −0.053 | 0.137* | 0.056 | 0.019 | −0.044 | |
| 3-Caffeoylquinic acid | 0.166* | 0.192* | −0.062 | −0.121* | −0.001 | 0.169* | 0.108 | 0.037 | −0.030 | |
| Disuccinoylquinic acid | 0.061 | 0.122* | 0.023 | −0.092 | −0.059 | 0.126* | 0.046 | 0.017 | −0.046 | |
| 3-Feruloylquinic acid | 0.100 | 0.156* | −0.004 | −0.104 | −0.040 | 0.146* | 0.069 | 0.023 | −0.039 | |
| 4,5-Dicaffeoylquinic acid | 0.061 | 0.122* | 0.023 | −0.092 | −0.059 | 0.126* | 0.046 | 0.017 | −0.046 | |
| 4-Caffeoylquinic acid | 0.156* | 0.196* | −0.054 | −0.111 | 0.011 | 0.160* | 0.106 | 0.031 | −0.020 | |
| 4-Feruloylquinic acid | 0.163* | 0.199* | −0.057 | −0.107 | 0.010 | 0.161* | 0.108 | 0.029 | −0.017 | |
| 5-Caffeoylquinic acid | 0.136* | 0.177* | −0.052 | −0.123* | 0.006 | 0.164* | 0.104 | 0.039 | −0.035 | |
| 5-Feruloylquinic acid | 0.167* | 0.201* | −0.061 | −0.106 | 0.014 | 0.161* | 0.110 | 0.029 | −0.015 | |
| Caffeic acid | 0.160* | 0.171* | −0.119* | −0.065 | 0.112 | 0.096 | 0.117* | 0.013 | 0.020 | |
| Caffeoyl-glucose | 0.061 | 0.122* | 0.023 | −0.092 | −0.059 | 0.126* | 0.046 | 0.017 | −0.046 | |
| Ferulic acid | 0.028 | −0.021 | −0.032 | 0.049 | 0.033 | 0.103 | 0.035 | −0.049 | 0.035 | |
| o-Coumaric acid | 0.021 | −0.059 | −0.040 | 0.043 | 0.015 | 0.121* | 0.037 | −0.026 | 0.019 | |
| p-Coumaric acid | 0.047 | 0.057 | −0.119* | −0.062 | 0.089 | 0.091 | 0.130* | −0.102 | −0.018 | |
| trans-Ferulic acid | −0.033 | 0.047 | 0.123* | 0.120 | 0.054 | −0.071 | −0.102 | −0.010 | 0.077 | |
| Lariciresinol | 0.141* | −0.024 | −0.106 | −0.070 | 0.091 | 0.100 | 0.086 | 0.008 | −0.049 | |
| Pinoresinol | 0.152* | −0.030 | −0.112 | −0.067 | 0.073 | 0.099 | 0.085 | 0.012 | −0.050 | |
Zero-order correlations are presented as Pearson’s r coefficients (*P<0.05).
PD, postpartum day; BMI, body mass index; BFP, body fat percentage; MET, metabolic equivalent task; E, employment; EL, educational level; EBF, exclusive breastfeeding.